Syneos Health Inc, founded in 2018 and headquartered in Morrisville, North Carolina, is a leading biopharmaceutical solutions organization focused on accelerating the delivery of therapies to patients. The company offers a range of services that bridge the gap between clinical development and commercial launch, including clinical research, commercial solutions, and consulting services, aimed at optimizing the drug development process for its clients.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| SYNH 9.00% 2030-10-01 USDSyneos Health Inc | United States | 2030-10-01 | 9.000 | 7.55 |
| SYNH 9.00% 2030-10-01 USDSyneos Health Inc | United States | 2030-10-01 | 9.000 | 7.57 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Syneos Health has a notable history of bond issuances, first entering the market in 2020, with significant offerings to support its growth and acquisitions in the evolving healthcare landscape. A standout issuance was the $400 million senior notes sale, which garnered investor attention due to its favorable terms and alignment with the company's strategic initiatives. Currently, yields on Syneos bonds are competitive compared to industry averages, reflecting investor confidence and the firm’s solid operational performance. Additionally, the company's debt strategy includes features like call options, providing flexibility in managing its financing needs as it continues to expand.